Previous 10 | Next 10 |
Laboratorio Curie Expands Relationship with SOPHiA GENETICS PR Newswire The SOPHiA DDM™ Platform will help Laboratorio Curie advance its research into BRCA gene mutations BOSTON and ROLLE, Switzerland , Sept. 13, 2023 /PRNewswire/ -- SOPHiA GEN...
SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform PR Newswire With the help of the SOPHiA DDM™ Platform, IRST has introduced a new diagnostic kit that will support data- driven treat...
CHU Bordeaux is live on SOPHiA GENETICS PR Newswire The hospital is using the SOPHiA DDM™ Platform to advance the research of Homologous Recombinati on Repair Mutated Cancers BOSTON and ROLLE, Switzerland , Aug. 30, 2023 /PRNewswire/ --...
2023-08-22 06:51:02 ET More on SOPHiA Genetics SOPHiA GENETICS SA ( SOPH ) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on SOPHiA Genetics Earnings data for SOPHiA Genetics For further details see: SOPHiA GENETICS expands relat...
SOPHiA GENETICS Expands Relationship with Gustave Roussy PR Newswire Gustave Roussy uses SOPHiA DDM™ Platform to empower confident, data-driven medicine in the fight against cancer BOSTON and ROLLE, Switzerland , Aug. 22, 2023 /PRNewswire/ -- S...
A.O.U. San Giovanni di Dio Ruggi d'Aragona Expands Usage of SOPHiA GENETICS DDM™ Platform PR Newswire The Hospital will use the SOPHiA DDM™ Platform to advance its research and diagnosis of blood cancers BOSTON and ROLLE, Switzerland , Aug....
2023-08-12 12:24:07 ET SOPHiA GENETICS SA (SOPH) Q2 2023 Earnings Conference Call August 8, 2023, 8:30 AM ET Company Participants Katherine Bailon - Head, Investor Relations Dr. Jurgi Camblong - Co-Founder and CEO Ross Muken - Chief Financial Officer and COO ...
2023-08-08 07:57:10 ET SOPHiA Genetics press release ( NASDAQ: SOPH ): Q2 GAAP EPS of -$0.33 misses by $0.02 . Revenue of $15.1M (+29.1% Y/Y) misses by $0.14M . For further details see: SOPHiA Genetics GAAP EPS of -$0.33 misses by $0.02, revenue of $15.1M...
BOSTON and ROLLE, Switzerland, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for the second quarter ended June 30, 2023. Recent Highlights Revenue for the ...
Tulane University School of Medicine Uses SOPHiA GENETICS to Advance Research of Blood Cancers PR Newswire The School of Medicine will use the SOPHiA DDM™ Platform to expand its hematologic testing program for blood cancers BOSTON and ROLLE, Switzerland ...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...